Loading the evidence…
Follow an intervention from preclinical studies to human trials and reported outcomes.
| THERAPY / MECHANISM | INJURY MODELS | STUDIES | REPORTED OUTCOME | Open record |
|---|---|---|---|---|
| Thymoquinone Thymoquinone (bioactive constituent of Nigella sativa); no curated ChEMBL mechanism record | Chemical/toxin · Crush | 32016–2019 | Not approved | |
| Ulinastatin (urinary trypsin inhibitor) Biologic | Crush · Ischaemia-reperfusion +4 | 82011–2020 | Not approved | |
| Valproic acid Succinate semialdehyde dehydrogenase inhibitor | TBI · Spinal cord injury +2 | 72010–2017 | No trauma translation |
Study counts are reported at therapy level and can differ from the number of itemised publications. Outcomes are research classifications, not treatment recommendations.